A global, phase I, pharmacokinetic study investigating bevacizumab biosimilar [MYL-1402O]
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 09 Dec 2015 New trial record
Latest Information Update: 09 Dec 2015